European health and social care systems are under intense pressure. An ageing population and increased prevalence of non-communicable diseases create huge costs for our economies and societies.

At a time when health budgets are strained, public finances are under pressure, the health workforce crisis is deepening, and Europe faces unprecedented geopolitical challenges, we need to rethink healthcare.

Join us on 21 April to discuss how we can break the cycle, reduce avoidable long-term costs, and improve the lives of European patients.

Register here.

Cardiovascular disease causes almost four million deaths in Europe, costing €282 billion annually. Yet much of this burden is preventable.

For people living with atherosclerotic cardiovascular disease (ASCVD), better secondary prevention could significantly reduce the risk of future heart attacks and strokes.The challenge? A persistent gap between clinical guidelines and real-world implementation across Europe.

The LSE paper explores the lifetime benefits that optimised secondary prevention could deliver in seven European countries for patients with ASCVD.

Read the full paper here.